-
24/05/2023 REPROCELL offers mesenchymal stem cell based CDMO services to manufacture Advanced Therapies Medicinal ProductsYokohama Japan, 24 May 2023 REPROCELL will now offer CDMO services to manufacture Advanced Therapies...
-
17/01/2023 Histocell takes part in the new European project NABIHEAL in biomaterials for complex wound healingThe Horizon Europe project NABIHEAL, coordinated by the Center for Biomedical Research Network (CIBER) at...
-
09/01/2023 FORCE REPAIRCURRENT PROJECTS FORCE REPAIR January 2023 - December 2026 Grant agreement: 101092243 “SMART AND MULTIFUNCTIONAL...
-
09/01/2023 NABIHEALCURRENT PROJECTS NABIHEAL January 2023 - December 2026 Grant Agreement: 101092269 “ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX...
-
23/11/2022 Japanese company REPROCELL invests in HistocellREPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem...
-
17/11/2022 Histocell inaugurates new manufacturing plant for advanced therapy medicinal productsHistocell has inaugurated this morning its manufacturing plant in Larrabetzu, dedicated to cell therapy and...
-
01/04/2022 PLASMINCURRENT PROJECTS PLASMIN April 2022 - December 2023 Reference no: ZL-2022/00789 Call: HAZITEK COMPETITIVO 2022...
-
01/04/2022 ITEASCURRENT PROJECTS ITEAS April 2022- December 2024 Reference no: ZE-2022/00021 Call: HAZITEK ESTRATEGICO 2022 Project...
-
31/05/2021 Cardiva expands its business by acquiring a stake in the biopharmaceutical company HistocellThe company has decided to join one of the most renowned Spanish companies in the...
-
08/02/2021 Histocell and Cardiva join forces to introduce the innovative wound care product Reoxcare throughout the Spanish healthcare system.The Basque biopharmaceutical company Histocell and the company Cardiva join forces to introduce the innovative...
- 1
- 2